Detalhe da pesquisa
1.
2022 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty.
J Arthroplasty
; 37(9): 1676-1683, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35732511
2.
CD8 T cells and mTOR: new concepts and targets for systemic lupus erythematosus.
Lancet
; 391(10126): 1126-1127, 2018 03 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-29551336
3.
HRES-1/Rab4-mediated depletion of Drp1 impairs mitochondrial homeostasis and represents a target for treatment in SLE.
Ann Rheum Dis
; 73(10): 1888-97, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-23897774
4.
2022 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty.
Arthritis Care Res (Hoboken)
; 74(9): 1399-1408, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35718887
5.
2022 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty.
Arthritis Rheumatol
; 74(9): 1464-1473, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35722708
6.
Activation of mammalian target of rapamycin controls the loss of TCRzeta in lupus T cells through HRES-1/Rab4-regulated lysosomal degradation.
J Immunol
; 182(4): 2063-73, 2009 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-19201859
7.
T-cell and B-cell signaling biomarkers and treatment targets in lupus.
Curr Opin Rheumatol
; 21(5): 454-64, 2009 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-19550330
8.
The A4396G polymorphism in interferon regulatory factor 1 is frequently expressed in breast cancer cell lines.
Cancer Genet Cytogenet
; 175(1): 61-4, 2007 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-17498560
9.
interferon regulatory factor-1 mediates the proapoptotic but not cell cycle arrest effects of the steroidal antiestrogen ICI 182,780 (faslodex, fulvestrant).
Cancer Res
; 64(11): 4030-9, 2004 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-15173018
10.
Prevention of hepatocarcinogenesis and increased susceptibility to acetaminophen-induced liver failure in transaldolase-deficient mice by N-acetylcysteine.
J Clin Invest
; 119(6): 1546-57, 2009 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-19436114
11.
Interferon regulatory factor-1 (IRF-1) exhibits tumor suppressor activities in breast cancer associated with caspase activation and induction of apoptosis.
Carcinogenesis
; 26(9): 1527-35, 2005 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-15878912